Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

84.37
Delayed Data
As of 4:02pm ET
 +0.27 / +0.32%
Today’s Change
66.93
Today|||52-Week Range
86.90
+15.83%
Year-to-Date
Ophthotech's Fovista Combo Regimen Disappoints in Phase III
11:19am / Zacks.com - Paid Partner Content
Hugh Johnson Advisors LLC Buys Vanguard Total International Stock ETF, iShares 1-3 Ye...
Aug 10 / GuruFocus News - Paid Partner Content
Catalyst (CPRX) Focused on Development of Pipeline Candidates
Aug 15 / Zacks.com - Paid Partner Content
The Medicines Company (MDCO) Q2 Loss Widens, Revenues Miss
Aug 10 / Zacks.com - Paid Partner Content
Can Ligand's Captisol Deals Boost Growth in the Long Run?
Aug 15 / Zacks.com - Paid Partner Content
Kite Pharma (KITE) Q2 Loss Narrower than Expected, Shares Up
Aug 09 / Zacks.com - Paid Partner Content
Are Amgen's New Drugs Doing Well Enough to Drive Sales?
Aug 15 / Zacks.com - Paid Partner Content
Ligand (LGND) Q2 Earnings & Revenues Top, 2017 View Raised
Aug 08 / Zacks.com - Paid Partner Content